A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma - Rampling, R; Peoples, S; Mulholland, P J (Clin Cancer Res, 2016)
et al.